NVO - Novo Nordisk A/S

NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Dec 2019)Next qtr. (Mar 2020)Current year (2019)Next year (2020)
No. of analysts1022
Avg. Estimate0.5502.42.73
Low estimate0.5502.372.73
High estimate0.5502.432.73
Year ago EPS0.530.662.522.4
Revenue estimateCurrent qtr. (Dec 2019)Next qtr. (Mar 2020)Current year (2019)Next year (2020)
No. of analysts1022
Avg. Estimate4.68BN/A17.98B19.06B
Low estimate4.68BN/A17.96B18.85B
High estimate4.68BN/A18B19.27B
Year ago sales4.55BN/A17.7B17.98B
Sales growth (year/est)2.70%N/A1.50%6.00%
Earnings history30/12/201830/03/201929/06/201929/09/2019
Est. EPS0.570.620.610.62
Actual EPS0.530.660.610.64
Difference-0.040.0400.02
Surprise %-7.00%6.50%0.00%3.20%
EPS trendCurrent qtr. (Dec 2019)Next qtr. (Mar 2020)Current year (2019)Next year (2020)
Current estimate0.5502.42.73
7 days ago0.5502.42.77
30 days ago0.5602.422.79
60 days ago0.5702.42.78
90 days ago0.5802.442.82
EPS revisionsCurrent qtr. (Dec 2019)Next qtr. (Mar 2020)Current year (2019)Next year (2020)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesNVOIndustrySectorS&P 500
Current qtr.3.80%N/AN/A0.01
Next qtr.N/AN/AN/A0.06
Current year-4.80%N/AN/A-0.03
Next year13.80%N/AN/A0.14
Next 5 years (per annum)9.60%N/AN/A0.07
Past 5 years (per annum)5.69%N/AN/AN/A
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more